Valuing patient quality of life: treatment of cancer-associated thrombosis and extended therapy.

Open Access

Valuing patient quality of life: treatment of cancer-associated thrombosis and extended therapy.

Session: The beginning of the end for NOACs? The extra mile

Topic: Atrial Fibrillation (AF)

Speaker: Professor R. Bauersachs (Frankfurt am Main, DE) Doctor M. Patel (Durham, US) Professor C. Becattini (Perugia, IT)

About the speakers

Professor Rupert Bauersachs

CCB at Agaplesion Bethanien Hospital, Frankfurt am Main (Germany)

10 presentations

1 follower

Doctor Manesh Patel

Duke University Medical Center, Durham (United States of America)

30 presentations

1 follower

Professor Cecilia Becattini

University of Perugia, Perugia (Italy)

14 presentations

0 follower

6 more presentations in this session

Introduction.

Speaker: Doctor M. Patel (Durham, US)

Access

How has our approach to the treatment of frail, older patients with atrial fibrillation evolved?

Speaker: Doctor M. Patel (Durham, US) Doctor C. Coleman (Storrs, US) Associate Professor E. Arbelo (Barcelona, ES)

Access

Understanding the impact of NOACs on the treatment of venous thromboembolism in vulnerable patients.

Speaker: Professor R. Bauersachs (Frankfurt am Main, DE) Doctor M. Patel (Durham, US) Professor C. Becattini (Perugia, IT)

Access

Patient with atrial fibrillation, chronic kidney disease and diabetes: how can they be protected from further renal decline?

Speaker: Doctor M. Patel (Durham, US) Doctor C. Coleman (Storrs, US) Associate Professor E. Arbelo (Barcelona, ES)

Access

Live Q&A.

Access

Access the full session

The beginning of the end for NOACs? The extra mile

Speakers: Professor R. Bauersachs, Doctor M. Patel, Professor C. Becattini, Doctor M. Patel, Doctor M. Patel...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Valuing patient quality of life: treatment of cancer-associated thrombosis and extended therapy.

About the speakers

Professor Rupert Bauersachs

Doctor Manesh Patel

Professor Cecilia Becattini

6 more presentations in this session

Introduction.

How has our approach to the treatment of frail, older patients with atrial fibrillation evolved?

Understanding the impact of NOACs on the treatment of venous thromboembolism in vulnerable patients.

Patient with atrial fibrillation, chronic kidney disease and diabetes: how can they be protected from further renal decline?​

Live Q&A.

Access the full session

The beginning of the end for NOACs? The extra mile​

About the event

ESC Congress 2022

ESC 365 is supported by

Patient with atrial fibrillation, chronic kidney disease and diabetes: how can they be protected from further renal decline?

The beginning of the end for NOACs? The extra mile